PDT Partners LLC Sells 1,214 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

PDT Partners LLC reduced its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 58.1% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 876 shares of the medical instruments supplier’s stock after selling 1,214 shares during the period. PDT Partners LLC’s holdings in Mettler-Toledo International were worth $1,314,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. PineStone Asset Management Inc. grew its holdings in Mettler-Toledo International by 127.4% during the second quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock worth $362,855,000 after buying an additional 145,453 shares in the last quarter. Loomis Sayles & Co. L P grew its stake in shares of Mettler-Toledo International by 1.8% in the 3rd quarter. Loomis Sayles & Co. L P now owns 209,902 shares of the medical instruments supplier’s stock worth $314,790,000 after acquiring an additional 3,644 shares in the last quarter. TD Asset Management Inc raised its holdings in shares of Mettler-Toledo International by 1.9% in the second quarter. TD Asset Management Inc now owns 157,247 shares of the medical instruments supplier’s stock valued at $219,767,000 after purchasing an additional 2,866 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its position in shares of Mettler-Toledo International by 32.5% during the second quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier’s stock valued at $199,777,000 after purchasing an additional 35,048 shares in the last quarter. Finally, International Assets Investment Management LLC boosted its holdings in Mettler-Toledo International by 149,870.0% during the third quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier’s stock worth $134,946,000 after purchasing an additional 89,922 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Wells Fargo & Company decreased their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research note on Monday, November 11th. Stifel Nicolaus decreased their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Evercore ISI boosted their price objective on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Robert W. Baird decreased their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday, November 11th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a report on Monday, August 5th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Mettler-Toledo International has a consensus rating of “Hold” and a consensus price target of $1,338.75.

Mettler-Toledo International Stock Performance

MTD stock opened at $1,251.20 on Monday. The stock has a fifty day moving average of $1,345.17 and a 200-day moving average of $1,392.37. Mettler-Toledo International Inc. has a fifty-two week low of $1,068.33 and a fifty-two week high of $1,546.93. The company has a market capitalization of $26.40 billion, a price-to-earnings ratio of 33.73, a PEG ratio of 4.13 and a beta of 1.16.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The firm had revenue of $954.54 million during the quarter, compared to analyst estimates of $941.93 million. Equities analysts predict that Mettler-Toledo International Inc. will post 40.42 EPS for the current year.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the stock in a transaction on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the sale, the director now owns 240 shares in the company, valued at $314,820. This represents a 24.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.94% of the stock is owned by company insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.